-+ 0.00%
-+ 0.00%
-+ 0.00%

ANTENGENE ANNOUNCES FIRST PATIENT DOSED IN PIVOTAL PHASE III CLINCH-3 STUDY OF ATG-022

路透·09/21/2026 00:30:00

登录查看新闻详情